X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
12
PharmaCompass offers a list of Sodium Hydrogenphosphate Dihydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Hydrogenphosphate Dihydrate manufacturer or Sodium Hydrogenphosphate Dihydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Hydrogenphosphate Dihydrate manufacturer or Sodium Hydrogenphosphate Dihydrate supplier.
PharmaCompass also assists you with knowing the Sodium Hydrogenphosphate Dihydrate API Price utilized in the formulation of products. Sodium Hydrogenphosphate Dihydrate API Price is not always fixed or binding as the Sodium Hydrogenphosphate Dihydrate Price is obtained through a variety of data sources. The Sodium Hydrogenphosphate Dihydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sodium phosphate, dibasic, heptahydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium phosphate, dibasic, heptahydrate, including repackagers and relabelers. The FDA regulates Sodium phosphate, dibasic, heptahydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium phosphate, dibasic, heptahydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium phosphate, dibasic, heptahydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium phosphate, dibasic, heptahydrate supplier is an individual or a company that provides Sodium phosphate, dibasic, heptahydrate active pharmaceutical ingredient (API) or Sodium phosphate, dibasic, heptahydrate finished formulations upon request. The Sodium phosphate, dibasic, heptahydrate suppliers may include Sodium phosphate, dibasic, heptahydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium phosphate, dibasic, heptahydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium phosphate, dibasic, heptahydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium phosphate, dibasic, heptahydrate active pharmaceutical ingredient (API) in detail. Different forms of Sodium phosphate, dibasic, heptahydrate DMFs exist exist since differing nations have different regulations, such as Sodium phosphate, dibasic, heptahydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium phosphate, dibasic, heptahydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium phosphate, dibasic, heptahydrate USDMF includes data on Sodium phosphate, dibasic, heptahydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium phosphate, dibasic, heptahydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium phosphate, dibasic, heptahydrate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sodium phosphate, dibasic, heptahydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sodium phosphate, dibasic, heptahydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sodium phosphate, dibasic, heptahydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sodium phosphate, dibasic, heptahydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sodium phosphate, dibasic, heptahydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sodium phosphate, dibasic, heptahydrate suppliers with NDC on PharmaCompass.
Sodium phosphate, dibasic, heptahydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium phosphate, dibasic, heptahydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium phosphate, dibasic, heptahydrate GMP manufacturer or Sodium phosphate, dibasic, heptahydrate GMP API supplier for your needs.
A Sodium phosphate, dibasic, heptahydrate CoA (Certificate of Analysis) is a formal document that attests to Sodium phosphate, dibasic, heptahydrate's compliance with Sodium phosphate, dibasic, heptahydrate specifications and serves as a tool for batch-level quality control.
Sodium phosphate, dibasic, heptahydrate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium phosphate, dibasic, heptahydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium phosphate, dibasic, heptahydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium phosphate, dibasic, heptahydrate EP), Sodium phosphate, dibasic, heptahydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium phosphate, dibasic, heptahydrate USP).
Market Place
